Publications by authors named "Edward Tabor"

Claim this Profile
P
Proceed to your nearest emergency room … and wait.
Edward Tabor

Acad Emerg Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complex pathway to United States Food and Drug Administration approval of Smoflipid.
Edward Tabor

JPEN J Parenter Enteral Nutr· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
Edward Tabor

N Engl J Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tutorial on How the US Food and Drug Administration Regulates Parenteral Nutrition Products.
Edward Tabor

JPEN J Parenter Enteral Nutr· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Status of Multi-Trace Element Products for Parenteral Nutrition in the United States.
Edward Tabor

Nutr Clin Pract· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Gut Microbiome: What We Do and Don't Know".
Edward Tabor

Nutr Clin Pract· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prepublication culture in clinical research.
Edward Tabor

Lancet· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food and Drug Administration Requirements for Clinical Studies in Pediatric Patients.
Edward Tabor

Ther Innov Regul Sci· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
As the FDA begins to address new types of lipid emulsions for parenteral nutrition: using the basis for approvals in past years as a springboard for discussion.
Edward Tabor

Nutr Clin Pract· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteria by the book.
Edward Tabor, Louis B Rice

Science· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis of hepatitis B virus-associated hepatocellular carcinoma.
Edward Tabor

Hepatol Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infections by hepatitis B surface antigen gene mutants in Europe and North America.
Edward Tabor

J Med Virol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEN virus: epidemiology and characteristics of a transfusion-transmitted virus.
Jun Akiba, Takeji Umemura, Harvey J Alter, Masamichi Kojiro, Edward Tabor

Transfusion· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of antibody after hepatitis B vaccine and the question of boosters.
Edward Tabor

Hepatology· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas.
Rin Yamaguchi, Seiya Momosaki, Guang Gao, Chu Chieh Hsia, Masamichi Kojiro, Edward Tabor

Int J Mol Med· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV core antigen as an alternative to NAT to detect HCV viremia.
Christina A Raker, Edward Tabor, Akihiko Okayama, Mei-ying W Yu, Michinori Kohara

Transfusion· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.
Robin Biswas, Edward Tabor, Chu Chieh Hsia, David J Wright, Megan E Laycock

Transfusion· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients.
Guang Gao, Zelma Buskell, Leonard Seeff, Edward Tabor

J Med Virol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAT screening of blood and plasma donations: evolution of technology and regulatory policy.
Edward Tabor, Jay S Epstein

Transfusion· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis